secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2026-08-27T12:30:16+00:00
Accession:  0001683168-26-006742
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Valion Bio announces 1-for-25 reverse stock split to regain Nasdaq compliance
-----------------------------------------------------------------------------

- 1-for-25 reverse stock split effective Aug 31, 2026; trading symbol VBIO unchanged, new CUSIP 918942202.
- Split aims to regain Nasdaq $1.00 minimum bid price compliance; prior notice from Nasdaq on Mar 19, 2026, deadline Sep 15, 2026.
- Stockholders approved split at special meeting Aug 14, 2026; fractional shares rounded up, no cash paid.
- Proportionate adjustments to preferred stock, warrants, options, and 2021 equity incentive plan shares.
- Transfer agent Odyssey acts as exchange agent; no action needed for book-entry or broker-held shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000168316826006742/0001683168-26-006742-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000168316826006742/valion_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-006742

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer